Headline: U.S. mutual fund discloses small direct equity holding in Ripple Labs — but it’s not XRP Kinetics Internet Portfolio reported holding 1,875 Class A shares of Ripple Labs valued at $246,318.75 as of June 30, according to a quarterly regulatory filing that became public in August. With the fund’s net assets listed at $248.28 million, that stake represented roughly 0.0992% of net assets. Why this matters - The filing confirms direct equity exposure to Ripple Labs by a regulated U.S. mutual fund — not exposure to the XRP token. Equity and XRP are legally and economically distinct. - Because Ripple is privately held, the $246,318.75 figure is a fund valuation (Level 3), not a market price from an exchange or evidence of a completed trade. Numbers and context - The fund’s June disclosure contrasts with earlier media summaries that described Kinetics as a $275 million fund with a roughly $150,000 Ripple position; the primary filing places net assets just under $250 million and values the private shares at about $246k. - The same 1,875-share quantity appears in Kinetics’ March 31 schedule, but was then listed as 1,875 Ripple preferred A shares with a fair value of $228,281 and a cost basis of $300,000. The June filing lists them as “Common A Shares” at a higher fair value — up roughly $18,038 (about 7.9%) from March to June. What we don’t know - The unchanged share count means the June filing alone doesn’t prove Kinetics bought shares during the quarter. The shift from “preferred” to “common” could reflect a conversion, reclassification, or simply a revised description; neither filing explains the change, so drawing conclusions would be speculative. - Because these are Level 3 assets, valuation relies on unobservable inputs — there’s no active market price for private Ripple shares. Legal and regulatory backdrop - The disclosure arrives while the SEC is considering a proposed framework called Regulation Crypto Assets, but that proposal does not blur the line between private equity and crypto tokens. The SEC has said conventional equity offerings remain best handled under existing securities rules. - Separately, Ripple’s long-running SEC litigation ended with appeals dismissed in August 2025, leaving a $125 million penalty and an injunction related to certain institutional sales. The court found programmatic XRP exchange sales were not investment contracts in the examined circumstances, but some direct institutional sales did violate securities laws. That case concerns XRP sales and does not change the nature of Ripple equity. Bottom line This verified filing shows a U.S. mutual fund held a small, privately valued equity position in Ripple Labs at quarter end. It confirms institutional equity exposure but does not prove a recent purchase, indicate an imminent IPO, or equate to any direct investment in XRP. Future Kinetics filings may reveal whether the fund keeps, increases, or exits the 1,875-share position or clarify whether the description change resulted from conversion or accounting reclassification. Ripple has not announced an IPO timeline. Read more AI-generated news on: undefined/news